Using microRNA to target the amyloidogenic pathway, the regulatory role of BACE1 and APP has been demonstrated in experimental models of AD utilizing mice that have been manipulated to accumulate amyloid in the brain as their primary pathology [47]. Here, BACE1 is linked to Alzheimer disease.